MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF
- PMID: 25201063
- DOI: 10.1007/s13277-014-2560-2
MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF
Abstract
MicroRNAs (miRNAs) play critical roles in the development and progression of ovarian cancer. We found that miR-212 was significantly downregulated in serum and tissues from epithelial ovarian cancer (EOC) patients. Overexpression of miR-212 in ovarian cancer cells inhibited cell proliferation, migration, and invasion. Luciferase reporter assay confirmed HBEGF as a direct target of miR-212. Overexpression of miR-212 decreased HBEGF expression at both the protein and messenger RNA (mRNA) levels. Knockdown of HBEGF expression in SKOV3 cell line significantly inhibited cell growth, migration, and invasion. HBEGF mRNA level was upregulated in EOC tissues and inversely correlated with miR-212 expression in tissues. Upregulation of HBEGF could attenuate the effect induced by miR-212. These findings indicate that miR-212 displays a tumor-suppressive effect in human ovarian cancer. And miR-212 suppresses cell proliferation, migration, and invasion by targeting the HBEGF transcript, highlighting the therapeutic potential of miR-212 and HBEGF in epithelial ovarian cancer treatment.
Similar articles
-
MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.Mol Med Rep. 2017 Dec;16(6):9777-9785. doi: 10.3892/mmr.2017.7790. Epub 2017 Oct 13. Mol Med Rep. 2017. PMID: 29039517
-
RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.Mol Cancer. 2015 Feb 4;14(1):31. doi: 10.1186/s12943-015-0304-6. Mol Cancer. 2015. PMID: 25649143 Free PMC article.
-
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.Cancer Med. 2020 May;9(10):3500-3521. doi: 10.1002/cam4.2929. Epub 2020 Mar 13. Cancer Med. 2020. PMID: 32167655 Free PMC article.
-
Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.Front Med. 2017 Jun;11(2):214-222. doi: 10.1007/s11684-017-0518-7. Epub 2017 May 4. Front Med. 2017. PMID: 28470508
-
MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.Oncotarget. 2014 Dec 15;5(23):12291-303. doi: 10.18632/oncotarget.2577. Oncotarget. 2014. PMID: 25460499 Free PMC article.
Cited by
-
Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN.In Vitro Cell Dev Biol Anim. 2017 Feb;53(2):149-156. doi: 10.1007/s11626-016-0093-2. Epub 2016 Sep 23. In Vitro Cell Dev Biol Anim. 2017. PMID: 27663866
-
A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.Int J Gynecol Cancer. 2017 Jan;27(1):3-10. doi: 10.1097/IGC.0000000000000846. Int J Gynecol Cancer. 2017. PMID: 27636713 Free PMC article.
-
EGF receptor ligands: recent advances.F1000Res. 2016 Sep 8;5:F1000 Faculty Rev-2270. doi: 10.12688/f1000research.9025.1. eCollection 2016. F1000Res. 2016. PMID: 27635238 Free PMC article. Review.
-
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.Int J Mol Sci. 2020 Sep 25;21(19):7093. doi: 10.3390/ijms21197093. Int J Mol Sci. 2020. PMID: 32993038 Free PMC article. Review.
-
MicroRNA-212 Targets Mitogen-Activated Protein Kinase 1 to Inhibit Proliferation and Invasion of Prostate Cancer Cells.Oncol Res. 2018 Aug 23;26(7):1093-1102. doi: 10.3727/096504018X15154112497142. Epub 2018 Jan 10. Oncol Res. 2018. PMID: 29321092 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical